Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc.

Overview
Date Founded

2007

Headquarters

9700 63rd Ave No Suite 200 Maple Grove, Minnesota, 55369, United States

Type of Company

Public

Employees (Worldwide)

116

Industries

Medical Products & Equipment
Hospitals & Patient Services
Appliances & Electronics
Pharmaceuticals
Biotechnology

Company Description

Inspire Medical Systems, Inc. engages in the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control, and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Maple Grove, MN.

Contact Data
Trying to get in touch with decision makers at Inspire Medical Systems, Inc.? Subscribe today to access their professional contact information.
Executives & Employees

President, Chief Executive Officer, Secretary & Director

Chief Financial Officer & Head-Investor Relations

Chief Compliance Officer & Vice President-Human Resources

Senior Vice President, Sales & Marketing

Vice President, Research

Vice President, Marketing

Vice President-Product Development, Operations & Quality

Vice President, Commercial Operations-Europe

Vice President, Global Market Access

Vice President-Health Economics

Board of Directors

Chair at Mayo Clinic - Arizona

President & Chief Executive Officer at Beaver-Visitec International, Inc.

Partner, Amzak Health at Amzak Capital Management LLC

Private Equity Partner at OrbiMed Advisors LLC

General Partner at U.S. Venture Partners

President, Chief Executive Officer, Secretary & Director at Inspire Medical Systems, Inc.

Chief Medical Officer at CardioKinetix, Inc.

Former Chief Financial Officer at Wright Medical Group NV

Paths to Inspire Medical Systems, Inc.
Potential Connections via
Relationship Science
You
Inspire Medical Systems, Inc.
Owners & Shareholders
Details Hidden

OrbiMed Advisors focuses on investments in the global healthcare industry. The firm invests across the spectrum of life sciences companies from early-stage private biotechnology companies to large, publicly-traded pharmaceutical companies. OrbiMed Advisors manages investments across three strategies: mutual funds, hedge funds and private equity funds. The firm is also known to engage in shareholder activist investment strategies.OrbiMed Advisors' hedge fund strategy invests both long and short in the health sciences sector. OrbiMed employs a global investment approach that provides a broad opportunity set and reduced volatility through diversification. They take long positions primarily in small-cap and mid-cap companies with products with the potential for future 'blockbuster' potential.OrbiMed Advisors' mutual funds also invest globally in health sciences companies. Funds under management include the Eaton Vance Worldwide Health Sciences Fund and the Finsbury Worldwide Pharmaceutical Trust. The Eaton Vance Worldwide Health Sciences Fund is a publicly-offered open-end mutual fund that invests globally in biotechnology and pharmaceutical investment opportunities. The Finsbury Worldwide Pharmaceutical Trust is a closed-end UK Investment Trust which also invests globally in biotechnology and pharmaceutical investment opportunities.The firm's private equity activities focus drug discovery, drug development and medical device companies. The firm invests across all stages of company development with particular emphasis on mid- and later-stage private companies. OrbiMed Advisors is generally the lead investor in their portfolio companies and often takes an active role on those companies' boards of directors.

Details Hidden

OrbiMed Advisors focuses on investments in the global healthcare industry. The firm invests across the spectrum of life sciences companies from early-stage private biotechnology companies to large, publicly-traded pharmaceutical companies. OrbiMed Advisors manages investments across three strategies: mutual funds, hedge funds and private equity funds. The firm is also known to engage in shareholder activist investment strategies.OrbiMed Advisors' hedge fund strategy invests both long and short in the health sciences sector. OrbiMed employs a global investment approach that provides a broad opportunity set and reduced volatility through diversification. They take long positions primarily in small-cap and mid-cap companies with products with the potential for future 'blockbuster' potential.OrbiMed Advisors' mutual funds also invest globally in health sciences companies. Funds under management include the Eaton Vance Worldwide Health Sciences Fund and the Finsbury Worldwide Pharmaceutical Trust. The Eaton Vance Worldwide Health Sciences Fund is a publicly-offered open-end mutual fund that invests globally in biotechnology and pharmaceutical investment opportunities. The Finsbury Worldwide Pharmaceutical Trust is a closed-end UK Investment Trust which also invests globally in biotechnology and pharmaceutical investment opportunities.The firm's private equity activities focus drug discovery, drug development and medical device companies. The firm invests across all stages of company development with particular emphasis on mid- and later-stage private companies. OrbiMed Advisors is generally the lead investor in their portfolio companies and often takes an active role on those companies' boards of directors.

Recent Transactions
Details Hidden

Inspire Medical Systems, Inc. issued Common Stock

Details Hidden

Inspire Medical Systems, Inc. raised money in a private placement transaction

Details Hidden

Inspire Medical Systems, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Details Hidden
Details Hidden
Transaction Advisors
Escrow Agent

Advised onInspire Medical Systems, Inc. issued Common Stock

Underwriter

Advised onInspire Medical Systems, Inc. issued Common Stock

Auditor

Advised onInspire Medical Systems, Inc. issued Common Stock

Legal Advisor

Advised onInspire Medical Systems, Inc. issued Common Stock

Legal Advisor

Advised onInspire Medical Systems, Inc. issued Common Stock

Key Stats and Financials As of 2017
Market Capitalization
$899M
Total Enterprise Value
Earnings Per Share
$-0.82
Revenue
$28.6M
Net Profit
$-17.5M
EBITDA
$-15.7M
EBITDAMargin
-55.02%
Total Debt
$16.5M
Total Equity
$1.33M
Investors
Details Hidden

Medtronic was founded in 1949 as a medical equipment repair shop by Earl Bakken and his brother-in-law, Palmer Hermundslie. Since then, we've grown into a multinational company that uses technology to transform the way debilitating, chronic diseases are treated.Our first life-changing therapy – a wearable, battery-powered cardiac pacemaker – was the foundation for dozens more Medtronic therapies that use our electrical stimulation expertise to improve the lives of millions of people. Over the years, we adapted additional technologies for the human body, including radio frequency therapies, mechanical devices, drug and biologic delivery devices, and diagnostic tools. Today, our technologies are used to treat more than 30 chronic diseases affecting many areas of the body.

Details Hidden

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded on January 26, 2015 and is headquartered in Dublin, Ireland.

Details Hidden

Amzak Capital Management makes business development, debt and equity investments in a range of industries domestically and internationally. They consider investments from a control perspective, as well as minority investments across the capital structure. The firm typically seeks to invest $3 million to $20 million per debt or minority interest transaction, with notably higher amounts possible for control transaction either alone or through partnerships with other investors. Amzak Capital Management is the investment vehicle for the Kazma family which focuses on investments in the telecommunications sector in North America, the Caribbean and Latin America.

Suppliers
Integer Holdings Corporation Medical Products & Equipment | Frisco, TX

Integer Holdings Corp. engages in manufacturing and developing medical devices and components. It operates through Medical and Non-Medical segments. The Medical segment include cardio and vascular; cardiac and neuromodulation; and advanced surgical, orthopedics, and portable medical. The Non-Medical segment focuses on lithium cells, and primary and secondary battery packs for applications in the energy, military and environmental markets.The company was founded by Wilson Greatbatch in 1970 and is headquartered in Frisco, TX.

Cirtec Medical Systems, LLC Holding Companies | Enfield, CT

Cirtec Medical Systems LLC provides outsourced design and manufacturing services for neuro-stimulation and cardiovascular devices. The firm is a complete medical device consulting firm for both large manufacturers and smaller start ups. The company was founded in 2009 by Laurence S. Derose, Merwin Jerry Hansen and Michael Forman and is headquartered in Los Gatos, CA.

Medtronic Plc Medical Products & Equipment | Dublin, DU

Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded on January 26, 2015 and is headquartered in Dublin, Ireland.

Competitors
LivaNova PLC Medical Products & Equipment - London, GL

LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the Cardiac Surgery and Neuromodulation, and Other Corporate segments. The Cardiac Surgery and Neuromodulation segment corresponds to the primary therapeutic areas. The Other Corporate segment includes corporate business development and New Ventures. The company was founded on October 19, 2015 and is headquartered in London, the United Kingdom.